Trial intelligence / Profile preview

Meditoxin vs Botox in Post Stroke Upper Limb Spasticity

NCT01313767Phase 3Completed

Sponsor
Medytox Inc.
Start
Mar 2011
Primary completion
Jan 2012
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 3 trial of Meditoxin in spasticity, sponsored by Medytox Inc.. Started Mar 2011; status: completed.

02

Drugs

Meditoxin
03

Conditions

spasticity

Beyond the preview

Go deeper on NCT01313767.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01313767.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call